A Life Sciences Investment Firm & Valued Strategic and Execution Partner

Significant Unmet Medical Needs

Invests in entrepreneur scientists working on platform technologies across services, therapeutics, and diagnostics to address large, unmet medical needs in oncology, neurosciences, and rare diseases.

Antimicrobial Resistance

Invest in entrepreneurs with disruptive technologies across therapeutics, services, vaccines, and diagnostics to bring their innovations to market and address other solutions for the growing burden of AMR.

Kineticos brought a methodical approach, experienced resources, and industry contacts to help advance our projects to a swift conclusion.

Bob Jones, CEO, Acura Pharmaceuticals

The insights Kineticos provided on a strategic portfolio assessment were highly actionable, and we have implemented a new strategy based on the findings – a hugely successful project!

Oliver Schacht, CEO, OpGen

Our strategic work with Kineticos provided us immense fire power to reach out to biopharmaceutical companies interested in partnering our gene, CRISPR and cell therapy programs.

Oscar Segurado, CMO, ASC Therapeutics

We engaged with Kineticos to research a new market for a potential investment. The insights were immediately actionable, the team was highly responsive, and communication was excellent.

David Anderson, General Partner, Ampersand

On numerous occasions the Kineticos team has promptly and diligently conducted market research through KOLs and data driven insights.”

Mark Bamforth, CEO, Arranta Bio

Our Customers

Brammer Bio  Logo
Advaxis, Inc  Logo
Vitruvias  Logo
Curetis NV  Logo
vTv Therapeutics  Logo
Viracor Eurofins  Logo
LabConnect  Logo

Contact Us

If you are seeking help, more information, or would like to discuss your next initiative with our experts, contact us today.

Kineticos Life Sciences
9131 Anson Way
Suite 110
Raleigh, NC 27615

This field is for validation purposes and should be left unchanged.